<DOC>
	<DOCNO>NCT02261545</DOCNO>
	<brief_summary>The aim study determine effect supplementation n-3 fatty acid placebo 10 week expression Sirt-1 , AdipoR1 &amp; AdipoR2 gene peripheral blood mononuclear cell ( PBMC ) circulatory level Resistin , MCP-1 Adiponectin type2 diabetes patient</brief_summary>
	<brief_title>The Effect n-3 Fatty Acid Supplementation Serum Levels , Gene Expression type2 Diabetes Patient</brief_title>
	<detailed_description>The aim study determine effect supplementation n-3 fatty acid placebo 10 week expression Sirt-1 , AdipoR1 ( adiponectin receptor 1 ) &amp; AdipoR2 ( adiponectin receptor 2 ) gene peripheral blood mononuclear cell ( PBMC ) circulatory level Resistin , MCP-1 ( Monocyte Chemoattractant Protein-1 ) Adiponectin type2 diabetes patient . In randomized , double-blind clinical trial , placebo-controlled , 88 men woman type 2 diabetes enrol study Iranian Diabetes Association . After sign informed consent individual complete general information form , 24-hour food recall 3 day beck depression questionnaire take participant begin end study . Selected sample randomly classify 2 block group receive supplement placebo . The supplement group , receive mg 1800mg EPA ( Eicosapentaenoic acid ) &amp; 900mg DHA ( docosahexaenoic acid ) ( total=2700mg ) 10 week placebo group also receive placebo ( contain 2700 mg edible paraffin ) ( similar term color , shape size ) . Patients recommend sustain diet medication dose ( ) study also advise maintain constant level physical activity . Blood sample collect 12 hour fast anthropometric variable , biochemical parameter , target gene expression physical activity trial measure</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>willingness participation , diabetic patient 30 60 year old , body mass index range 2540 , avoidance dietary supplement , vitamin herbal product least 3 month throughout intervention people use n3 Fatty Acid Supplementation last 3 month , chronic renal disease , GI disease , Hepatobiliary diseases , hematological disorder , hypo hyperthyroidism , type 1 diabetes , treatment orlistat sibutramine weight loss , pregnancy lactation , treatment insulin Thiazolidinediones .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>n-3 fatty acid</keyword>
	<keyword>Sirt-1</keyword>
	<keyword>AdipoR1</keyword>
	<keyword>AdipoR2</keyword>
	<keyword>MCP-1</keyword>
	<keyword>Adiponectin</keyword>
	<keyword>Resistin</keyword>
	<keyword>T2DM</keyword>
</DOC>